Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 2158-2165, May 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hishiki, T.
Right arrow Articles by Nakagawara, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hishiki, T.
Right arrow Articles by Nakagawara, A.

Glial Cell Line-derived Neurotrophic Factor/Neurturin-induced Differentiation and Its Enhancement by Retinoic Acid in Primary Human Neuroblastomas Expressing c-Ret, GFR{alpha}-1, and GFR{alpha}-21

Tomoro Hishiki, Yoshinori Nimura, Eriko Isogai, Kazuhiro Kondo, Shingo Ichimiya, Yohko Nakamura, Toshinori Ozaki, Shigeru Sakiyama, Masayoshi Hirose, Naohiko Seki, Hideyo Takahashi, Naomi Ohnuma, Masahiro Tanabe and Akira Nakagawara2

Divisions of Biochemistry [T. H., Y. Ni., E. I., K. K., S. I., Y. Na., T. O., S. S., A. N.] and Clinical Examination [M. H.], Chiba Cancer Center Research Institute, Chiba 260-8717; Laboratory of Gene Structure I, Kazusa DNA Research Institute, Chiba 292-0812 [N. S.]; and Department of Pediatric Surgery, Chiba University School of Medicine, Chiba 260-8670 [T. H., H. T., N. O., M. T.], Japan

Neuroblastomas often undergo spontaneous differentiation and/or regression in vivo, which is at least partly regulated by the signals through neurotrophins and their receptors. Recently, glial cell line-derived neurotrophic factor (GDNF) and a second family member, neurturin (NTN), have been found to mediate their signals by binding to a heterotetrameric complex of c-Ret tyrosine kinase receptors and glycosylphosphatidylinositol-linked proteins, GFR{alpha}-1 (GDNFR-{alpha}) or GFR{alpha}-2 (TrnR2/GDNFR-ß/NTNR-{alpha}/RETL2). Here, we studied the effect of GDNF and NTN on human neuroblastomas in the short-term primary culture system, as well as the expression of c-Ret, GFR{alpha}-1, GFR{alpha}-2, GDNF, and NTN. GDNF (1–100 ng/ml) induced morphological differentiation in 34 of 38 primary neuroblastomas and an accompanying increase in c-Fos induction. These effects were markedly enhanced by treatment with 5 µM all-trans-retinoic acid. Although GDNF alone induced a rather weak differentiation independent of the disease stages, the enhancement of neurite outgrowth induced by treatment with both GDNF and all-trans-retinoic acid was significantly correlated with younger age (less than 1 year; P = 0.0039), non-stage 4 diseases (P = 0.0023), a single copy of N-myc (P = 0.027), and high levels of TRK-A expression (P = 0.0062). To examine the expression levels of GFR{alpha}-1, we cloned a short form of the human GFR{alpha}-1 gene with a 15-bp deletion by screening a human adult substantia nigra cDNA library. Many primary neuroblastomas expressed c-Ret, GFR{alpha}-1, and GFR{alpha}-2 as well as their ligands, GDNF and NTN, suggesting the presence of a paracrine or autocrine signaling system within the tumor tissue. The effect of NTN on primary culture cells of neuroblastoma was similar to that of GDNF. These imply that the GDNF(NTN)/c-Ret/GFR{alpha}-1(GFR{alpha}-2) signaling may have an important role in regulating the growth, differentiation, and cell death of neuroblastomas.

1 Supported in part by a grant-in-aid from the Ministry of Health and Welfare for a New Comprehensive 10-Year Strategy for Cancer Control, Japan.

2 To whom requests for reprints should be addressed, at Division of Biochemistry, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuoh-ku, Chiba 260-8717, Japan. Phone: 81-43-264-5431; Fax: 81-43-265-4459; E-mail: akiranak@biolab.kazusa.or.jp.

Received 10/29/97. Accepted 3/18/98.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
B. Lu and M. PereiraPerrin
A Novel Immunoprecipitation Strategy Identifies a Unique Functional Mimic of the Glial Cell Line-Derived Neurotrophic Factor Family Ligands in the Pathogen Trypanosoma cruzi
Infect. Immun., August 1, 2008; 76(8): 3530 - 3538.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. Beaudry, M. Nilsson, M. Rioth, D. Prox, D. Poon, L. Xu, P. Zweidler-Mckay, A. Ryan, J. Folkman, S. Ryeom, et al.
Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium
Mol. Cancer Ther., February 1, 2008; 7(2): 418 - 424.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
L. Cerchia, A. D'Alessio, G. Amabile, F. Duconge, C. Pestourie, B. Tavitian, D. Libri, and V. de Franciscis
An Autocrine Loop Involving Ret and Glial Cell-Derived Neurotrophic Factor Mediates Retinoic Acid-Induced Neuroblastoma Cell Differentiation
Mol. Cancer Res., July 1, 2006; 4(7): 481 - 488.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Shen, Z. Jia, R. G. Nagele, H. Ichikawa, and G. S. Goldberg
Src Uses Cas to Suppress Fhl1 in Order to Promote Nonanchored Growth and Migration of Tumor Cells
Cancer Res., February 1, 2006; 66(3): 1543 - 1552.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Vargas-Leal, R. Bruno, T. Derfuss, M. Krumbholz, R. Hohlfeld, and E. Meinl
Expression and Function of Glial Cell Line-Derived Neurotrophic Factor Family Ligands and Their Receptors on Human Immune Cells
J. Immunol., August 15, 2005; 175(4): 2301 - 2308.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Alaminos, V. Davalos, N.-K. V. Cheung, W. L. Gerald, and M. Esteller
Clustering of Gene Hypermethylation Associated With Clinical Risk Groups in Neuroblastoma
J Natl Cancer Inst, August 18, 2004; 96(16): 1208 - 1219.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Matsunaga, H. Shirasawa, T. Hishiki, H. Yoshida, K. Kouchi, Y. Ohtsuka, K. Kawamura, T. Etoh, and N. Ohnuma
Enhanced Expression of N-myc Messenger RNA in Neuroblastomas Found by Mass Screening
Clin. Cancer Res., August 1, 2000; 6(8): 3199 - 3204.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
E. Hashino, E. M. Johnson Jr, J. Milbrandt, M. Shero, R. J. Salvi, and C. S. Cohan
Multiple Actions of Neurturin Correlate with Spatiotemporal Patterns of Ret Expression in Developing Chick Cranial Ganglion Neurons
J. Neurosci., October 1, 1999; 19(19): 8476 - 8486.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.